European Journal of Medicinal Chemistry p. 1011 - 1019 (2000)
Update date:2022-08-02
Topics:
Gaubert, Gilles
Mathe, Christophe
Imbach, Jean-Louis
Eriksson, Staffan
Vincenzetti, Silvia
Salvatori, Daniela
Vita, Alberto
Maury, Georges
Although 2'-deoxy-β-D-5-azacytidine (Decitabine) and β-D-5-azacytidine display potent antileukemic properties, their therapeutic use is hampered by their sensitivity to nucleophiles and to deamination catalysed by cytidine deaminase. As shown earlier [Shafiee M., Griffon J.-F., Gosselin G., Cambi A., Vincenzetti S., Vita A., Erikson S., Imbach J.-L., Maury G., Biochem. Pharmacol. 56 (1998) 1237-1242], β-L-enantiomers of cytidine derivatives are resistant to cytidine deaminase. We thus synthesized several 5-azacytosine β-L-nucleoside analogues to evaluate their enzymatic and biological properties. 2'-Deoxy-β-L-5-azacytidine (L-Decitabine), β-L-5-azacytidine, 1-(β-L-xylo-furanosyl)5-azacytosine, and 1-(2-deoxy-β-L-threo-pentofuranosyl)5-azacytosine were stereospecifically prepared starting from L-ribose and L-xylose. D- and L-enantiomers of 2'-deoxy-β-5-azacytidine were weak substrates of human recombinant deoxycytidine kinase (dCK) compared to β-D-deoxycytidine, whereas both enantiomers of β-5-azacytidine or the L-xylo-analogues were not substrates of the enzyme. As expected, none of the presently reported derivatives of β-L-5-azacytidine was a substrate of human recombinant cytidine deaminase (CDA). The prepared compounds were tested for their activity against HIV and HBV and they did not show any significant activity or cytotoxicity. In the case of L-Decitabine, this suggests that the enantioselectivities of concerned enzymes other than dCK and CDA might not be favourable. (C) 2000 Editions scientifiques et medicales Elsevier SAS.
View MoreYicheng Goto Pharmaceuticals Co.,Ltd.
Contact:+86 710 3423122
Address:5th Floor,East Gate of Building #2,Servo-Industrial Park,1st Qilin Road,Xiangyang,Hubei,China
Chengdu Aslee Biopharmaceuticals, Inc
Contact:18608018419
Address:Chengdu Aslee Biopharmaceuticals, Inc
website:http://www.uvchemkeys.com
Contact:0086-021-58785816
Address:RM2607 Building No.1 Guosheng, Lane 388, Zhongjiang Road, Putuo District, Shanghai 200062 China
Lanling Hongchuang Flame Retardant Co., Ltd.
Contact:+86-531-68858132
Address:East Huafeichang Road, Cangshan County, Linyi, Shandong, China (Mainland)
Anhui Dexinjia Biopharm Co., Ltd
Contact:+86-531-82375818
Address:9 Hexie Road, kaifaqu, Taihe
Doi:10.1002/1521-3773(20001201)39:23<4308::AID-ANIE4308>3.0.CO;2-4
(2000)Doi:10.1016/S0040-4020(01)00893-6
(2001)Doi:10.5560/ZNB.2014-4001
(2014)Doi:10.1021/ja00787a041
(1973)Doi:10.1016/j.molstruc.2020.128461
(2020)Doi:10.1016/0040-4020(65)80030-8
(1965)